Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Robert B. Berkowitz"'
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 6:183-189
Background Nasal, noninhaled carbon dioxide (CO 2 ) was shown to be effective for the treatment of symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis in single application studies. Objective To assess the efficacy of as-need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9743f3ad793dc7bce569cb3896844a4f
https://doi.org/10.1016/j.jaip.2017.05.028
https://doi.org/10.1016/j.jaip.2017.05.028
Autor:
Suzanne Meeves, Cheryl Lutz, Pat Jones, Santosh T. Varghese, Susan Braker, Robert B. Berkowitz, Chunfu Qiu, George Georges
Publikováno v:
Annals of Allergy, Asthma & Immunology. 96:327-333
Background To date, it is unknown whether fexofenadine mitigates the worsening of symptoms induced by the cat allergen Felis domesticus allergen 1. Objective To determine the effects of a single dose of fexofenadine hydrochloride, 180 mg, in preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5c9f03717a1fb5bf18257adf7cc1bc
https://doi.org/10.1016/s1081-1206(10)61243-4
https://doi.org/10.1016/s1081-1206(10)61243-4
Publikováno v:
Annals of Allergy, Asthma & Immunology. 89:372-380
Background and Objective The adverse effects of untreated seasonal allergic rhinitis (AR) on performance in the workplace, school, and home are poorly understood. To delineate more clearly the impact and consequences of the disease on performance, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf958782156eeb90778dffcca834089
https://doi.org/10.1016/s1081-1206(10)62038-8
https://doi.org/10.1016/s1081-1206(10)62038-8
Autor:
Keith Nolop, Judy E. Harrison, James P. Kemp, John J. Murray, S. David Miller, Robert B. Berkowitz
Publikováno v:
Journal of Allergy and Clinical Immunology. 106:485-492
Background: Despite current recommendations, many patients with persistent asthma are still treated with bronchodilators alone. Objective: The safety and efficacy of two once daily dosing regimens (200 μg and 400 μg) of mometasone furoate (MF) admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2faabc09a20c616d9a271cc512bfde3
https://doi.org/10.1067/mai.2000.109431
https://doi.org/10.1067/mai.2000.109431
Autor:
Julius van Bavel, George E. Stewart, Keith B. Nolop, Jay Grossman, Albert F. Finn, Eric J. Schenkel, David P. Skoner, Nathan Segall, Robert J. Dockhorn, Eli O. Meltzer, Ita Tripathy, Edwin A. Bronsky, Michael E. Ruff, Frank C. Hampel, Paul H. Ratner, Barbara Mesarina-Wicki, William E. Berger, Donald J. Dvorin, Robert Anolik, Allen T. Segal, Stanley P. Galant, Robert B. Berkowitz
Publikováno v:
Journal of Allergy and Clinical Immunology. 104:107-114
Background: The efficacy and safety of mometasone furoate aqueous nasal spray (MFNS; Nasonex) 200 μg once daily for the treatment and prophylaxis of seasonal allergic rhinitis (SAR) and treatment of perennial rhinitis have been demonstrated in adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4e3f6906729e9f39706f9a5ab8a9df
https://doi.org/10.1016/s0091-6749(99)70121-1
https://doi.org/10.1016/s0091-6749(99)70121-1
Autor:
Anthony R. Rooklin, Richard R. Lorber, David G. Tinkelman, Stephen I. Rennard, Richard C. Hubbard, Howard J. Zeitz, Burton A. Moss, Robert B. Berkowitz, J. Paul Marcoux
Publikováno v:
Journal of Asthma. 32:275-284
This multicenter, randomized, investigator-blinded, parallel group study compared the effects of converting patients from a q12h extended-release theophylline preparation (Theo-Dur) to a q24h extended-release product (Uni-Dur). Patients (n = 133) fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0a3a336336709bbc079a0073615ff8
https://doi.org/10.3109/02770909509044835
https://doi.org/10.3109/02770909509044835
Publikováno v:
Journal of Asthma. 28:243-249
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cfe78027a37757ec9d0d7d9cf9daa7
https://doi.org/10.3109/02770909109073380
https://doi.org/10.3109/02770909109073380
Autor:
Bruce M. Prenner, Stanley P. Galant, George W. Bensch, Robert B Berkowitz, Barry N. Lutsky, Joe W. Ramsdell
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 96(4)
In a previous study, a 200-microg once-daily evening dose of mometasone furoate dry powder inhaler (DPI) was effective in patients with asthma previously taking inhaled corticosteroids. No studies have been conducted to test the effect of a once-dail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0482e837e23c00a99eabed16bedaeb17
https://pubmed.ncbi.nlm.nih.gov/16680920
https://pubmed.ncbi.nlm.nih.gov/16680920
Publikováno v:
The Journal of allergy and clinical immunology. 115(4)
R112 inhibits Syk kinase, a transducer of signaling through the Fcepsilon receptor of mast cells, blocking mast cell responses to allergic stimuli.Examine the efficacy and safety of intranasal R112 in volunteers with symptomatic seasonal allergic rhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc8bfb2dfc681f8b76f74042e9942d1
https://pubmed.ncbi.nlm.nih.gov/15806000
https://pubmed.ncbi.nlm.nih.gov/15806000
Autor:
Robert B, Berkowitz, Frank, McCafferty, Cheryl, Lutz, Donna, Bazelmans, Penny, Godfrey, Suzanne, Meeves, Yuning, Liao, George, Georges
Publikováno v:
Allergy and asthma proceedings. 25(5)
Although antihistamine-decongestant combinations are frequently used for allergic rhinitis, published data about the onset of action of these combination agents are limited. This randomized, double-blind, placebo-controlled, parallel-group study inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c01b940fa804f36171eed0d6cc20aebd
https://pubmed.ncbi.nlm.nih.gov/15603207
https://pubmed.ncbi.nlm.nih.gov/15603207